Bard C R Inc (BCR) Return on Assets ROA from the third quarter of 2017 to third quarter of 2016 and for the year 2017, Average High and Low, Fundamental Ratios from Sep 30 2017 to Sep 30 2016 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bard C R Inc  (BCR)


Bard C R Inc's ROA from the third quarter of 2017 to the third quarter of 2016 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bard C R Inc's ROA in the third quarter of 2017?
Bard C R Inc achieved a return on average assets (ROA) of 10.64 % in its third quarter of 2017, which is below Bard C R Inc's average return on assets, which stands at 12.39%.

ROA decreased relative to the period ending Jun 30 2017, due to the decline in net income.

However, within the Healthcare sector 76 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2017 from 540 to 565.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2017)
III. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter
Y / Y Total Assets Change 4.93 % 8.29 % 1.31 % 7.35 % 6.8 %
Y / Y Net Income Change -2.39 % -11.81 % 53.27 % 17.09 % -
Net Income (TTM) in million 572 574 592 531 507
Return On Assets (TTM) 10.64 % 10.82 % 11.39 % 10.23 % 9.96 %
BCR's Total Ranking # 565 # 540 # 510 # 594 # 620
Total Assets (TTM) in million 5,573 5,354 5,245 5,306 5,311
Seq. Total Assets Change 4.08 % 2.08 % -1.16 % -0.09 % 7.42 %
Seq. Net Income Change -32.64 % -21.56 % 11.59 % 65.56 % -39.14 %

BCR's 5 Years Annual ROA >> Back to BCR Management Effectiveness >> Compare BCR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 26
Sector # 77
Overall # 506

Return On Assets Statistics
High Average Low
18.42 %
12.39 %
2.24 %
(Sep. 28, 2009)   (Mar 31 2016)





Financial Statements
Bard C R Inc's Assets $ 5,573 million BCR's Balance sheet
Bard C R Inc's Income $ 94 million Quarterly BCR's Income Statement
BCR's Income by Division See BCR's Income by Division



Annual Return On Assets (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (FY 2014)
FY (Dec. 31. 2014)		 (Dec 31 2013)
FY 2013		 (FY 2012)
FY (Dec. 31. 2012)
Y / Y Total Assets Change 7.35 % -2.94 % 0.7 % 21.83 % 1.79 %
Total Assets in million 5,306 4,943 5,093 5,057 4,151
Y / Y Net Income Change 292.47 % -54.02 % -57.31 % 30.13 % 61.62 %
Net Income in million 531 135 295 690 530
Annual Return On Assets 10.01 % 2.74 % 5.78 % 13.64 % 12.77 %

BCR's 5 Years Annual ROA >> Back to BCR Management Effectiveness >> Compare BCR ROA to its Competitors



Comment on BCR's ROA in the fiscal year ending 2016
In the fiscal year 2016 ROA improved to 10.01 % compared to prior year, due to annual net income growth of 292.47 % to $531.40 million, while value of Bard C R Inc's overall assets grew just by 7.35 % to $5,306.10 million, compared to $5,306.10 a year before.


More Return On Assets Ratios
BCR's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BCR's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BCR's Competitors
Subscribers only: Roa for Bard C R Inc's Suppliers
Subscribers only: Return On Assets for BCR's Customers

You may also want to know
BCR's Roi BCR's Inventory Turnover Ratio BCR's Growth Rates BCR's Dividend Comparisons
BCR's Profitability Ratios BCR's Asset Turnover Ratio BCR's Dividend Growth
BCR's Roe BCR's Valuation Ratios BCR's Financial Strength Ratios BCR's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2017, within Healthcare Sector ROA
Palatin Technologies Inc   29.08 %
Ligand Pharmaceuticals Incorporated  28.84 %
Innoviva Inc   26.40 %
Exelixis Inc   26.11 %
Luna Innovations Inc  25.75 %
Fonar Corporation  25.16 %
Iveric Bio Inc   24.91 %
Psychemedics Corporation  24.57 %
Alpha Pro Tech Ltd   21.84 %
Lineage Cell Therapeutics Inc   21.45 %
Sigyn Therapeutics Inc   19.40 %
United Therapeutics Corporation  19.37 %
Gilead Sciences Inc   19.33 %
Mettler toledo International Inc   19.17 %
Nrc Health  17.72 %
Align Technology inc   17.61 %
Atrion Corporation  17.52 %
Idexx Laboratories Inc  17.31 %
Supernus Pharmaceuticals inc   17.00 %
Biospecifics Technologies Corp  16.84 %
Utah Medical Products Inc  16.39 %
Remedent Inc   16.39 %
Jrsis Health Care Corp  16.38 %
Regeneron Pharmaceuticals Inc   16.38 %
Intuitive Surgical Inc   16.27 %
3m Company  16.25 %
Oramed Pharmaceuticals Inc  16.06 %
Cba Florida Inc   16.00 %
Biogen Inc   15.68 %
Illumina Inc   15.49 %

Date modified: 2026-09-08T15:08:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.